Shanghai Kinlita Chemical Co., Ltd.

SZSE:300225 Stock Report

Market Cap: CN¥3.3b

Shanghai Kinlita Chemical Balance Sheet Health

Financial Health criteria checks 5/6

Shanghai Kinlita Chemical has a total shareholder equity of CN¥854.9M and total debt of CN¥134.0M, which brings its debt-to-equity ratio to 15.7%. Its total assets and total liabilities are CN¥1.4B and CN¥508.1M respectively. Shanghai Kinlita Chemical's EBIT is CN¥28.3M making its interest coverage ratio 5.5. It has cash and short-term investments of CN¥117.6M.

Key information

15.7%

Debt to equity ratio

CN¥134.05m

Debt

Interest coverage ratio5.5x
CashCN¥117.63m
EquityCN¥854.88m
Total liabilitiesCN¥508.10m
Total assetsCN¥1.36b

Recent financial health updates

Recent updates

Shanghai Kinlita Chemical's (SZSE:300225) Earnings May Just Be The Starting Point

Nov 04
Shanghai Kinlita Chemical's (SZSE:300225) Earnings May Just Be The Starting Point

Does Shanghai Kinlita Chemical (SZSE:300225) Have A Healthy Balance Sheet?

Oct 29
Does Shanghai Kinlita Chemical (SZSE:300225) Have A Healthy Balance Sheet?

Shanghai Kinlita Chemical Co., Ltd. (SZSE:300225) Stock Rockets 38% As Investors Are Less Pessimistic Than Expected

Sep 30
Shanghai Kinlita Chemical Co., Ltd. (SZSE:300225) Stock Rockets 38% As Investors Are Less Pessimistic Than Expected

There's Been No Shortage Of Growth Recently For Shanghai Kinlita Chemical's (SZSE:300225) Returns On Capital

Jul 12
There's Been No Shortage Of Growth Recently For Shanghai Kinlita Chemical's (SZSE:300225) Returns On Capital

Shanghai Kinlita Chemical's (SZSE:300225) Strong Earnings Are Of Good Quality

May 03
Shanghai Kinlita Chemical's (SZSE:300225) Strong Earnings Are Of Good Quality

Financial Position Analysis

Short Term Liabilities: 300225's short term assets (CN¥712.2M) exceed its short term liabilities (CN¥477.7M).

Long Term Liabilities: 300225's short term assets (CN¥712.2M) exceed its long term liabilities (CN¥30.4M).


Debt to Equity History and Analysis

Debt Level: 300225's net debt to equity ratio (1.9%) is considered satisfactory.

Reducing Debt: 300225's debt to equity ratio has increased from 0% to 15.7% over the past 5 years.

Debt Coverage: 300225's debt is well covered by operating cash flow (125.2%).

Interest Coverage: 300225's interest payments on its debt are well covered by EBIT (5.5x coverage).


Balance Sheet


Discover healthy companies